Granulocytopenia after combined therapy with interferon and angiotensin-converting enzyme inhibitors: evidence for a synergistic hematologic toxicity.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  American Journal of Medicine

• Publication date

  1995-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0002-9343(99)80186-7PMID 7573094
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pancreatic Adenocarcinoma

  2019cited by this paper
• Enalapril

  2012cited by this paper
• Antinuclear and antinative DNA antibodies during captopril treatment.

  2009cited by this paper
• Combining interferon with cytotoxic chemotherapy in patients with advanced breast cancer

  2004cited by this paper
• Clinical Toxicity of the Interferons

  1994cited by this paper
• Membranoproliferative glomerulonephritis associated with hepatitis C virus infection responsive to interferon-alpha.

  1993cited by this paper
• Hepatitis C virus and cryoglobulinemia.

  1993cited by this paper
• alpha-Interferon therapy for hepatitis C virus chronic infection with mixed cryoglobulinemia.

  1993cited by this paper
• Hepatitis C virus and cryoglobulinemia. Latial cryoglobulinemia Cooperative Study Group.

  1993cited by this paper
• Membranoproliferative glomerulonephritis associated with hepatitis C virus infection

  1993cited by this paper
• Interferon alfa in leukocytoclastic vasculitis, mixed cryoglobulinaemia, and chronic hepatitis C.

  1993cited by this paper
• Interferon-alpha in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial.

  1993cited by this paper
• A role for hepatitis C virus infection in type II cryoglobulinemia.

  1992cited by this paper
• Effect of interferon-alpha 2b on cryoglobulinemia related to hepatitis C virus infection.

  1992cited by this paper
• Low-dose interferon-α for mixed cryoglobulinemia associated with hepatitis C virus

  1992cited by this paper
• Interferon : principles and medical applications

  1992cited by this paper
• Adverse effects of angiotensin-converting enzyme inhibitors in antihypertensive therapy with focus on quinapril.

  1992cited by this paper
• Low-dose interferon-alpha for mixed cryoglobulinemia associated with hepatitis C virus.

  1992cited by this paper
• Bone marrow hypoplasia and aplasia complicating interferon therapy for chronic myelogenous leukemia

  1992cited by this paper
• Cryoglobulinemia and hepatitis C virus.

  1992cited by this paper
• Phase II evaluation of fluorouracil and recombinant α‐2a‐interferon in previously untreated patients with pancreatic adenocarcinoma

  1992cited by this paper
• Agranulocytosis Associated with Enalapril

  1991cited by this paper
• Mixed cryoglobulinemia responsive to interferon-alpha.

  1991cited by this paper
• Long-term results of therapy with interferon-alpha for type II essential mixed cryoglobulinemia.

  1991cited by this paper
• Cryoglobulinaemia and hepatitis C virus.

  1991cited by this paper
• Mixed cryoglobulinemia responsive to interferon-α

  1991cited by this paper
• The interferons. Mechanisms of action and clinical applications.

  1991cited by this paper
• Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy.

  1990cited by this paper
• Enalapril-induced antinuclear antibodies.

  1990cited by this paper
• Clonal B cell expansions in patients with essential mixed cryoglobulinaemia.

  1989cited by this paper
• A Phase II Trial of Intermittent Leukocyte Interferon and High Dose Chlorambucil in the Treatment of Non-Hodgkin's Lymphoma Resistant to Conventional Therapy

  1989cited by this paper
• Treatment of idiopathic mixed cryoglobulinemia with alpha interferon.

  1987cited by this paper
• Current and future uses of recombinant interferon alpha in the treatment of low‐grade non‐Hodgkin's lymphoma

  1987cited by this paper
• Safety and tolerance of recombinant interferon alfa‐2a (roferon®‐A) in Cancer Patients

  1986cited by this paper
• Angioneurotic edema, agranulocytosis, and fatal septicemia following captopril therapy.

  1986cited by this paper
• Clinical toxicity of interferons in cancer patients: a review.

  1986cited by this paper
• Adverse effects profile of sulfhydryl compounds in man.

  1986cited by this paper
• Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

  1986cited by this paper
• Treatment of renal cell carcinoma with alpha (human leukocyte) interferon and vinblastine in combination: a phase I-II trial.

  1985cited by this paper
• Immune thrombocytopenia following alpha-interferon therapy in patients with cancer.

  1985cited by this paper
• Alpha interferon for induction of remission in hairy-cell leukemia.

  1984cited by this paper
• Development of antinuclear antibody in patients treated with high doses of captopril.

  1984cited by this paper
• Captopril-associated neutropenia. Who is at risk?

  1983cited by this paper
• Mechanism of captopril-induced agranulocytosis.

  1981cited by this paper
• Captopril-induced agranulocytosis in systemic sclerosis.

  1981cited by this paper
• Captopril-associated agranulocytosis.

  1980cited by this paper
• Captopril-associated agranulocytosis.

  1980cited by this paper
• Captopril and agranulocytosis.

  1980cited by this paper
• Endoscopic treatnent of biliary-tract diseases.

  1979cited by this paper
• Interferon affects both G1 and S+G2 in cells stimulated from quiescence to growth

  1978cited by this paper
• HODGKIN'S DISEASE MORTALITY AMONG PHYSICIANS

  1975cited by this paper
• The effects of an inhibiting factor (interferon) on the in vitro growth of granulocyte-macrophage colonies.

  1972cited by this paper

• Idiosyncratic Drug-Induced Neutropenia and Agranulocytosis in Elderly Patients

  2020cites this paper
• Evolving Role of Pharmacogenetic Biomarkers to Predict Drug-Induced Hematological Disorders.

  2020cites this paper
• Oral Contraceptives and Neutropenia: A Population-Based Cohort Study

  2019cites this paper
• Drug Interactions of Non-HIV Antiviral Agents

  2018cites this paper
• Chemistry and pharmacology of Angiotensin-converting enzyme inhibitors.

  2015cites this paper
• Non-HIV Antiviral Agents

  2011cites this paper
• Timing of captopril administration determines radiation protection or radiation sensitization in a murine model of total body irradiation.

  2010cites this paper
• Papel da enzima conversora de angiotensina-I na regulação hematopoética de animais normais e nocautes dos receptores B1 de cininas.

  2008cites this paper
• Treatment of hepatitis C with interferon-alpha and ribavirine in a patient with long-term clozapine treatment.

  2008cites this paper
• Chapter 12 Renal Disease in Cryoglobulinemic Vasculitis

  2007cites this paper
• A Role for Angiotensin‐Converting Enzyme in the Characterization, Enrichment, and Proliferation Potential of Adult Murine Pituitary Colony‐Forming Cells

  2006cites this paper
• [Renal damage during type II cryoglobulinemia].

  2003cites this paper
• Drugs acting on the immune system

  2003cites this paper
• [Interferon alpha-associated agranulocytosis during clozapine treatment. Case report and status of current knowledge].

  2001cites this paper
• Captopril inhibits in vitro and in vivo the proliferation of primitive haematopoietic cells induced into cell cycle by cytotoxic drug administration or irradiation but has no effect on myeloid leukaemia cell proliferation

  2000cites this paper
• Captopril Inhibits the Proliferation of Hematopoietic Stem and Progenitor Cells in Murine Long‐Term Bone Marrow Cultures

  1999cites this paper
• Glomerulonephritis in mixed cryoglobulinaemia: what treatment?

  1999cites this paper
• Interferon-alpha-induced agranulocytosis in a patient on long-term clozapine therapy.

  1998cites this paper
• Interferon toxicity in hepatitis C virus-associated type II cryoglobulinemia.

  1998cites this paper
• Interferon-α-induced agranulocytosis in a patient on long-term clozapine therapy

  1998cites this paper
• High plasma level of N-acetyl-seryl-aspartyl-lysyl-proline: a new marker of chronic angiotensin-converting enzyme inhibition.

  1997cites this paper
• Granulocytopenia after combined therapy with interferon and angiotensin- converting enzyme inhibitors: evidence for a synergistic hematologic toxicity.

  1996cites this paper
• Mixed cryoglobulinemia secondary to hepatitis C virus infection.

  1996cites this paper
• Case report: agranulocytosis induced by interferon-alpha therapy for chronic hepatitis C.

  1996cites this paper
• [Agranulocytosis caused by perindopril].

  1996cites this paper